Navigation Links
ORBIS International Announces the Death of the Honorable Oliver Foot, President and Board Member
Date:2/7/2008

NEW YORK, Feb. 7 /PRNewswire-USNewswire/ -- ORBIS International is saddened to announce the death of its president and member of the board of directors, the Honorable Oliver Foot. He was 61 years old.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080720/DC13663 )

Oliver's dedication to reduce human suffering caused by blindness was reflected in his work with ORBIS, a nonprofit global development organization that transcends cultural, political and religious differences by bringing people together to save sight worldwide. He once said, "ORBIS is at the heart of what life is all about -- promoting cooperation and understanding through serving others. What better way could there be to help heal our divided world?"

"Oliver's passing is of enormous import to ORBIS as an organization but also to a great many of us as individuals. He gave so much of himself and was such a kind and generous spirit that he was loved all over the world. He certainly meant a lot to me as a mentor, boss, friend and brother -- and I cannot imagine feeling any loss more deeply," said Geoffrey Holland, ORBIS executive director and chief executive officer. "I hope that while mourning the loss of such a very special friend, we can all also celebrate his life and remember what a pleasure it has been to know him."

Oliver joined ORBIS as executive director in 1982 and was appointed president in 1987. He was a member of the ORBIS International Board of Directors, as well as the boards of ORBIS Canada and ORBIS Taiwan. He also served as chairman of the ORBIS Charitable Trust in the United Kingdom.

Active with ORBIS since its founding 25 years ago, Oliver played a critical role in its development, fully devoting himself to its mission to eliminate avoidable blindness worldwide. He led the ORBIS team of volunteer doctors, nurses and aviators who flew to nearly 80 developing c
'/>"/>

SOURCE ORBIS International
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. ORBIS and Alcon Team Up to Provide Eye Care Education to School Students
2. FRC Urges Rejection of Lantos Bill That Funds International Abortionists
3. From Kent Hill, USAID Assistant Administrator for Global Health on the Observance of International Day of Zero Tolerance
4. Charles River Laboratories International Board Member Should Use Sarbanes-Oxley Disclosure Rules in Non-Profit Role, Asserts 1199 SEIU
5. Opportunity Internationals Micro Insurance Agency to Develop and Provide Life, Health and Crop Insurance for 21 Million Poor People
6. VWR International Publishes New Laboratory Casework and Technical Furniture Catalog
7. FY2009 Budget Increases International Development Funding but Does Little for Domestic Nutrition Programs
8. World Cancer Campaign Builds Momentum Globally with International Initiative to Protect Children From Secondhand Smoke
9. QED International Associates Announces Changes to the HealthShares(TM) Diagnostics Index
10. QED International Associates Announces Changes to the HealthShares(TM) European Medical Products and Devices Index
11. Mettler-Toledo International Inc. to Host Fourth-Quarter 2007 Earnings Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customer's Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders 2Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customer's Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders 3Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customer's Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders 4Maxygen, Inc. Announces Extension of Dutch Auction Tender Offer 2Boston Scientific Announces Pricing of $2 Billion of Senior Notes 2Boston Scientific Announces Pricing of $2 Billion of Senior Notes 3Webcast of QIAGEN N V s 28Nasdaq 3A QGEN 29 Second Quarter 2009 Financial Results Call Set for August 11 13355 1Webcast of QIAGEN N V s 28Nasdaq 3A QGEN 29 Second Quarter 2009 Financial Results Call Set for August 11 13355 2VIASPACE Pursuing Renewable Energy Business in Asia 13353 1VIASPACE Pursuing Renewable Energy Business in Asia 13353 2VIASPACE Pursuing Renewable Energy Business in Asia 13353 3Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures 13351 1Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures 13351 2Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures 13351 3Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures 13351 4Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures 13351 5Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures 13351 6